Get the Stockscreener App
14.86
8.63%
1.18
Integra Lifesciences Holdings Corp stock is traded at $14.86, with a volume of 1.44M.
It is up +8.63% in the last 24 hours and up +23.32% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$13.68
Open:
$13.84
24h Volume:
1.44M
Relative Volume:
1.16
Market Cap:
$1.16B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
29.72
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+4.72%
1M Performance:
+23.32%
6M Performance:
-29.67%
1Y Performance:
-27.05%
1-Day Range:
$13.84
$15.17
1-Week Range:
$13.64
$15.17
52-Week Range:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
14.86 | 1.09B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Will a bounce in Integra LifeSciences Holdings Corporation offer an exitMarket Performance Summary & Verified Technical Signals - Newser
Can machine learning forecast Integra LifeSciences Holdings Corporation recoveryLong Setup & Weekly Top Gainers Alerts - Newser
Unpacking the Artificial Skin Substitute Market's Evolution, - openPR.com
Cerebral Spinal Fluid Management Device Market Insights & - openPR.com
Technical analysis overview for Integra LifeSciences Holdings Corporation stockPortfolio Value Report & Free Safe Entry Trade Signal Reports - Newser
Candlestick signals on Integra LifeSciences Holdings Corporation stock todayJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Improved Revenues Required Before Integra LifeSciences Holdings Corporation (NASDAQ:IART) Stock's 27% Jump Looks Justified - 富途牛牛
Smart tools for monitoring Integra LifeSciences Holdings Corporation’s price action2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Is Integra LifeSciences Holdings Corporation trending in predictive chart modelsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Visual analytics tools that track Integra LifeSciences Holdings Corporation performance2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Using data models to predict Integra LifeSciences Holdings Corporation stock movementEarnings Overview Summary & Fast Momentum Stock Entry Tips - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationPortfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explainedQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Top chart patterns to watch in Integra LifeSciences Holdings CorporationMarket Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Applying chart zones and confluence areas to Integra LifeSciences Holdings Corporation2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationCEO Change & Fast Momentum Entry Tips - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisJuly 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Applying sector rotation models to Integra LifeSciences Holdings Corporation2025 Analyst Calls & Entry Point Strategy Guides - Newser
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser
Relative strength of Integra LifeSciences Holdings Corporation in sector analysis2025 Price Momentum & Daily Market Momentum Tracking - Newser
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook - Yahoo Finance
Developing predictive dashboards with Integra LifeSciences Holdings Corporation dataCEO Change & Free Community Consensus Stock Picks - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stock [Quarterly Growth Report]Free Weekly High Potential Stock Alerts - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionBuy Zone Strategy with Pattern Recognition - Newser
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation stock daily chart insightsConsistent Profit Signals with AI Models - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Integra Lifesciences (IART.O) Plunges 6.3% — What’s Behind the Sudden Drop? - AInvest
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):